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Abstract
Background: People with severe mental illness (SMI) are at increased risk of developing coronary
heart disease (CHD) and there is growing emphasis on the need to monitor their physical health.
However, there is little consensus on how services for the primary prevention of CHD should be
organised for this patient group. We explored the views of people with SMI and health
professionals from primary care and community mental health teams (CMHTs) on how best to
provide these services.
Methods: In-depth interviews were conducted with a purposive sample of patients with SMI (n =
31) and staff from primary care (n = 10) and community mental health teams (n = 25) in North
Central London. Transcripts of the qualitative interviews were analysed using a 'framework'
approach to identify the main themes in opinions regarding various service models.
Results: Cardiovascular risk factors in people with SMI were of concern to participants. However,
there was some disagreement about the best way to deliver appropriate care. Although staff felt
that primary care should take responsibility for risk factor screening and management, patients
favoured CHD screening in their CMHT. Problems with both approaches were identified. These
included a lack of familiarity in general practice with SMI and antipsychotic side effects and poor
communication of physical health issues to the CMHT. Lack of knowledge regarding CHD risk
factor screening and difficulties in interpreting screening results and implementing appropriate
interventions exist in secondary care.
Conclusion: Management of physical health care for people with SMI requires complex solutions
that cross the primary-secondary care interface. The views expressed by our participants suggest
that neither primary nor secondary care services on their own can provide a comprehensive
service for all patients. The increased risk of CHD associated with SMI and antipsychotic
medications requires flexible solutions with clear lines of responsibility for assessing,
communicating and managing CHD risks.
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Cardiovascular disease (CVD) is the leading cause of pre-
mature death in England and affects some population
groups more than others. In the UK, CVD mortality rates
have fallen less than in other developed countries [1],
even though the disease is largely preventable and the risk
factors are well understood [1]. The UK Government aims
to reduce coronary heart disease (CHD) and related disor-
ders by 40% in people under 75 by the year 2010. Their
National Service Framework (NSF) for Coronary Heart
Disease sets standards for primary prevention, emphasis-
ing the need to identify risk and then provide appropriate
advice and treatment to reduce this risk [1]. However, it
has been argued that there is a need for more research to
establish "the clinical, social and ethical acceptability" of
the mandated primary prevention interventions [2].
There is growing evidence that people with severe mental
illness (SMI) have a two-fold risk of dying from CHD in
comparison to the general population [3]. This excess of
CHD mortality is due to higher rates of smoking [4], dia-
betes [5] and dyslipidaemia [5]. It may be further com-
pounded by side effects of antipsychotic medication,
which include metabolic side effects such as diabetes mel-
litus and weight gain [6,7]. The NICE Guidelines for
Schizophrenia [8] highlight the need for monitoring the
physical health of patients with severe mental illness. Sec-
tion 1.4.1.3 of the document recommends that this
should include the monitoring of cardiovascular risk fac-
tors (including checks of blood pressure and lipids) and
diabetes, as well as lifestyle factors, such as smoking. The
guidelines recognise that some service users may not have
regular contact with their GP and recommend that, in
such cases, staff in secondary care services should monitor
the physical health of their patients.
People with SMI are as likely as the general population to
participate in screening for CHD risk factors when this is
offered [9]. Although there is a growing emphasis on
monitoring the physical health of people with SMI [6-8],
especially when prescribing certain atypical antipsychot-
ics, there is little evidence to guide the development of
services for screening for CHD risk factors such as diabetes
and dyslipidaemia. There is little consensus on how pri-
mary prevention of CHD risk should be organised, who is
best placed to undertake this task and what is required to
support screening. There are no data on the views of gen-
eral practice and community mental health team (CMHT)
staff or service users regarding the acceptability of screen-
ing for CHD risk factors. Obstacles to delivery of CHD
prevention in SMI remain unexplored and we know little
about patients' preferences. The role of primary and sec-
ondary care in primary prevention of CHD is poorly
defined. Although CHD prevention is traditionally the
remit of primary care, some patients are in more frequent
contact with CMHTs. Antipsychotic agents associated
with weight gain and possible metabolic disturbance are
usually initiated and monitored in secondary care.
We aimed to elicit the views of service users (people with
SMI) and professionals (i.e. primary care and community
mental health staff) on screening for CHD risk factors and
interventions for primary prevention of CHD. We sought
opinions regarding existing practice, obstacles to access-
ing care, preferred setting and different service models.
The qualitative study was a component of a wider research
programme which aimed to develop appropriate inter-
ventions to enhance primary prevention of CHD in peo-
ple with SMI. The other components of the programme
have included a systematic review of the literature on
CHD mortality, morbidity and risk factors in SMI; a sec-
ondary analysis of CHD mortality and morbidity data on
a large national cohort of people with and without SMI,
using the UK General Practice Research Database (GPRD);
and a large questionnaire survey of service users and
health professionals to explore a wider range of health
service issues related to the management of CHD in SMI.
Methods
We recruited participants from Central North London,
including staff and service users from CMHTs and general
practitioners (GPs) and practice nurses. We contacted a
sub-sample of local CMHT and GP practice managers to
inform them about the study. Having received the man-
ager's agreement, detailed information sheets were circu-
lated to individual team members with an invitation to
take part in an interview. We purposively recruited CMHT
staff from a range of disciplines to include community
psychiatric nurses, social workers, occupational thera-
pists, consultant and trainee psychiatrists, as well as gen-
eral practitioners and practice nurses.
Service users were invited via their consultant psychiatrists
or CMHT workers. Adults (age 18 to 65) with a diagnosis
of SMI (i.e. schizophrenia, schizoaffective disorder, bipo-
lar affective disorder or other non-organic psychotic ill-
ness) were eligible to participate in the interviews. Service
users were excluded if their current mental and/or physi-
cal health was such that it would prevent them from giv-
ing informed consent or participating in an interview.
Where a participant's first language was not English, we
were able to offer the services of an interpreter at the inter-
view. Service users were not excluded if they already had a
diagnosis of CHD.
Since service users were approached via their CMHT care
coordinators or consultant psychiatrists, none were
acutely unwell. They were therefore able to understand
information about the research, weigh up the risks andPage 2 of 12
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about whether to take part in an interview. As well as
receiving a detailed information sheet, service users and
staff had the opportunity to ask questions about the study
before agreeing to take part. Written and verbal informed
consent was obtained from all participants. The research
was carried out in accordance with the local research eth-
ics committee standards and the Helsinki declaration.
We sought health professionals' and service users' opin-
ions about primary prevention of heart disease in people
with SMI through individual face-to-face interviews. Each
interview was guided by a semi-structured schedule, with
initial open-ended questions to ascertain the participant's
general view or preference on each issue followed by more
in-depth or 'probing' questions to explore the reasons
underlying the view they had expressed. Where necessary,
prompts were used to encourage the interviewee to reflect
on key issues, if they had not raised these spontaneously.
At the end of the interview, participants were given the
opportunity to add any further views or comments that
they felt were important but which had not been covered
in the interview schedule. A semi-structured approach was
employed to ensure that we accessed and explored partic-
ipants' preferences in relation to the key issues relevant to
service development whilst still allowing the participant
some freedom to express their views on those key issues as
fully as they wished. There was scope within the schedule
for the ordering of the questions to be flexible where this
aided the flow of the discussion.
The questions were adapted to be relevant to primary care
staff, CMHT staff or people with SMI. The interviews
explored views on physical health care, the most appropri-
ate setting for screening and management, preferences for
different models in secondary and primary care, perceived
obstacles and problems with different models of care,
training needs and the willingness to deliver or receive
such care. We defined CHD screening as including routine
assessment of smoking status, elicitation of existing his-
tory of diabetes, total and HDL cholesterol, random glu-
cose, body mass index and ECG (where relevant), as well
as an assessment of diet and exercise. We explored views
on the following interventions: smoking cessation; weight
reduction; diet and exercise advice; and drug treatment of
hypertension, diabetes and dyslipidaemia.
Having heard participants' views on the primary care and
secondary care models, we then introduced the idea of a
specialist nurse-led model (if this had not already been
suggested spontaneously by the participant). In this
model, a physical health nurse attached to the CMHT
would liaise with primary care teams and CMHTs to
ensure that screening is regularly offered to clients with
SMI. A "solo-practitioner" model has been suggested as a
means of bridging the gap between primary and mental
health services, thus helping to overcome some of the bar-
riers that exist to adequate medical and preventive care for
people with SMI [10]. Furthermore, there has been a
recent move within the National Health Service (NHS)
towards specialist nurse-led services (e.g. in the fields of
cancer and diabetes care). Opinions were sought on the
general idea of a nurse-led service, without being prescrip-
tive as to the precise role such a specialist nurse might
adopt.
Patient interviews lasted 20–30 minutes and those with
staff 40–45 minutes. All participants were reimbursed ~20
for their time and expenses. All interviews were audio-
taped and transcribed by CAW. The interview transcripts
were analysed thematically using a 'framework' approach
[11]. The thematic framework was guided by the key top-
ics covered in the interview schedules, for instance atti-
tudes to CHD prevention work, where CHD screening
should take place, and what might be the main obstacles.
The data were charted using Excel 2002. Transcripts were
reviewed independently by two members of the research
team (CAW, DPJO) to identify common themes and
opinions emerging from participants' responses to each of
the key topics. Opinions regarding each theme were
extracted by each reviewer until saturation point had been
reached where no further different opinions were forth-
coming. These themes were agreed by consensus, with all
the researchers agreeing the final interpretations.
Results
We interviewed 31 patients with SMI (18 males and 13
females), aged between 28 and 67 years. The psychiatric
diagnoses were schizophrenia (n = 15), bipolar affective
disorder (n = 12) or schizoaffective disorder (n = 4) and
the majority were unable to work due to long-term sick-
ness or disability (n = 20). We also interviewed 35 health
professionals (14 males and 21 females), aged between 24
and 57 years. Ten staff worked in primary care and 25 in
CMHTs. They included community mental health nurses
(n = 10), social workers (n = 7), occupational therapists (n
= 1), psychiatrists (3 consultants, 2 registrars and 2 senior
house officers) and GPs (n = 8) and practice nurses (n =
2).
Importance of targeted CHD screening
There was a consensus view that screening for CHD risk
factors in people with SMI was an important priority for
health service resources, for which a range of reasons were
offered (see Table 1). People with SMI and the profession-
als were aware of the high prevalence of risk factors for
CHD. Professionals from all disciplines expressed concern
that services neglect the physical health of people with
SMI. Service users feared that their physical health needs
often "fell through the net". Concerns about the adversePage 3 of 12
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Table 1: Views on the importance of CHD risk factor screening and obstacles to its success
View expressed by *
Reasons cited for the importance of CHD screening in SMI CMHT GP SU N
• There is a high prevalence of smoking and weight problems among their own caseload with SMI 23
• Physical health is often neglected by services due to their focus on clients' mental health problems 20
• Side effects of antipsychotics, e.g. weight gain and metabolic 14
• Physical health can be neglected due to clients' poor motivation and social isolation – they need extra help and encouragement 
with this
13
• Research evidence indicates people with SMI are a high risk group for CHD 9
• Knowing about one's personal risk for CHD would enable clients to take timely preventative action (e.g. to make lifestyle 
changes)
8
• Regular screening would allay client's fears about their physical health 7
• Clients are aware of their own risk factors for CHD, especially smoking, family history, diet and weight 6
• Screening should be offered to everyone, regardless of SMI diagnosis 3
• Recent experience of clients with SMI dying due to undetected CHD 2
• The stress of having SMI may adversely affect the heart 2
• People with SMI are harder to engage and so need more assertive screening 2
• It is important for staff to recognise risk and be able to interpret any new physical symptoms as organic rather than psychological 
in nature
1
Perceived obstacles to/negative views of CHD screening
• Lack of appropriate resources in existing services – e.g. time, trained staff 18
• Anticipation of low uptake rates by patients with SMI 17
• Perceived difficulty in making lifestyle changes amongst people with SMI, even if risk CHD factors are identified 15
• Patients dislike having blood tests 12
• Lack of funding for CHD screening services or it not being seen as a priority by Trust management 12
• A screening offer might be viewed as interference in patients' lives – they may feel defensive, anxious or paranoid 7
• Stigma: a perception that services such as smoking cessation can't deal with people with SMI 4
• CMHT services already "squeezed" 4
• Staff resistance to more changes in their role – CHD screening would be moving too far away from their mental health role 4
• Poor communication of results between primary and secondary care 3
• Lack of appropriate services to refer patients to if risk factors are identified – e.g. long waiting lists, narrow referral criteria, group 
sessions
3
• It would not be cost effective to screen all SMI patients, only those in high risk groups e.g. overweight 2
• Prior experience of low attendance when routine screening appointments were offered to people with SMI in line with the new 
GP contract
1
* Note: Tick-boxes indicate which group(s) of participants expressed the view: CMHT = staff from community mental health team; GP = staff from general 
practice; SU = service users. Numbers (N) indicate the prevalence of each view within the total sample.
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edly articulated by staff and users.
I think it's very important because I think they [SMI] do
have significant problems in this area, partly because of
their lifestyle and partly because many of the drugs that
they're taking, especially the people on antipsychotics ...
atypical antipsychotics, you know, cause weight gain and
problems with blood pressure, some of the antidepres-
sants, so, you know ... the medication they're on predis-
poses them to risk factors for cardiac disease and diabetes
and weight gain and dyslipidaemia ... and I don't think
we're doing enough to adequately attend to those prob-
lems in this population (Consultant Psychiatrist 21).
I think it [check-ups] would be a great idea. I think actu-
ally ... not just a good idea, I think it's necessary. Because
otherwise they [people with SMI] will just fall through the
net ... when the only time they can get a medical check-up
is when they have a psychotic episode and they're brought
into hospital (Service User 17).
Many respondents expressed concerns that CHD preven-
tion would be very difficult in people with SMI. The obsta-
cles included low uptake rates, high current workload
within the CMHT and poor communication between GPs
and the CMHT (see Table 1).
Some of our mental health reviews that we're expected to
do ... getting people (with SMI) to actually turn up is very
difficult (General Practitioner 3).
Motivation and ability of staff to deliver primary 
prevention of CHD in SMI
Professionals expressed various attitudes to incorporating
CHD screening into their professional role. General prac-
tice staff stressed this was already a core component of
their work and expected to take on this role in people with
SMI. The UK primary care GMS contract requires practices
to maintain an SMI register and provide an annual physi-
cal health review to clients with SMI. However, some pri-
mary care staff identified lack of experience with SMI and
unfamiliarity with the CHD-related side effects of some
antipsychotic medications as obstacles. One practice
nurse stated that it was uncomfortable explaining that
individuals had been invited for a physical check-up due
to their inclusion on the practice SMI list.
I sort of felt a bit uncomfortable, because they came in and
said, "I've got this letter" [about screening appointment]
... and so you sort of skirt around it because you don't
want to say, "Oh, this is because you've got mental health
problems and you don't come to screening" (Practice
Nurse 04).
This unease about maintaining specific lists of people
with SMI was repeated by several staff and service users
who felt such lists or indeed special clinics were stigmatis-
ing or even "ghettoising". However some service users
(and staff) voiced an opposing view, stating that special
clinics for people with SMI gave them confidence that
their mental health problems would be understood.
I think I would appreciate a separate service for mentally
ill people, if I was going to my GP. Because I have a mental
illness, I sometimes ask too many questions and I feel a
bit sort of anxious about seeing the doctor whereas, if the
GP knew that I was mentally ill, he'd be more patient with
me if I was asking questions (Service User 10).
It would be stigmatising in a way, but I think these people
are stigmatised anyway. And I think probably people
would get lost in a more general clinic. That's just off the
top of my head. I could give you some reasons for both
[special vs. general clinics] ... but I think really, if we are
going to take people's physical health more seriously,
then I think probably to have dedicated services ... a ded-
icated clinic (Community Psychiatric Nurse 06).
Psychiatric staff rarely included formal assessment of
CHD risk factors in their routine practice although some
did discuss diet and exercise with patients. They expressed
more diverse views on their role in performing this task
than the primary care staff. Some viewed physical health
care as an essential part of their work and emphasised the
importance of an overall holistic approach to their
patient's problems.
I think it's holistic. Like I said, it's the whole package, isn't
it? You can't just ignore people's physical health and con-
centrate on their minds. I guess, as a social worker, we're
trained to kind of see the whole package, rather than sep-
arate little conditions ... or physical health and mental
health being split into two (Social Worker 02).
Other CMHT staff felt that physical health was the remit
of primary care and that it would be an inappropriate use
of their skills and time. They felt responsibility for screen-
ing would blur their professional roles. Moreover, they
lacked the expertise and resources to provide an adequate
primary prevention service for CHD.
I'm all for an holistic approach but ... if I was to speak
truthfully ... I'm up to my limit really with mental health
... you know, so it is difficult to even think about some of
these other issues because you've got so much else to focus
on ... I mean, not just the mental health but the ... all the
other stuff that at different levels ... you know, the social
aspects of people's lives and their housing problems andPage 5 of 12
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atric Nurse 06).
This diversity of this opinion was apparent across the pro-
fessional disciplines, with some psychiatrists, nurses and
social workers expressing a keen desire to include CHD
screening in their work. Similarly there were professionals
from all disciplines who were against conducting this
work.
Views of primary versus secondary care service models
Most CMHT and primary care staff initially responded
that screening would be best performed by primary care
services. They described the benefits of a system that is
already established to provide screening and relevant
interventions for risk factors that are detected.
I don't see why they [SMI] should be treated in a different
setting from other patients with the same condition,
Table 2: Primary care model for CHD risk factor screening in SMI: Advantages and disadvantages
View expressed by *
Perceived advantages of delivering CHD screening in primary care CMHT GP SU N
• GPs possess medical expertise in CHD screening and can provide appropriate management of results 14
• It is more normalising/less stigmatising to attend primary care for screening 13
• Patients attend the GP practice regularly to pick up their prescriptions, which would offer the opportunity for 
screening
7
• Clinical systems and equipment are all in place to provide screening 6
• Patients have better links, trust and a longer history with their GP, which would enhance the uptake of screening 6
• GPs can access other relevant physical health services more easily than the CMHT – they are the 'gate keepers' 6
• Geographically, GPs are often closer than the CMHT 6
• It would allow the CMHT to focus on mental health issues 2
• It would engage clients with their GP and encourage people with SMI to be less reliant on mental health services 2
Perceived disadvantages
• Lack of resources to provide this service due to GP's high workload 17
• High rates of non-attendance to general practice screening 8
• Specialist SMI screening clinics in primary care could be stigmatising 8
• Communication from primary to secondary care is very rare so psychiatrists won't receive screening results to inform 
prescribing
7
• Some patients get anxious about attending primary care and the more severely ill are often not in contact – they will 
not receive screening
7
• Some GPs may be negative towards or disinterested in people with SMI and offer a poor service to them – it could be 
a 'patchy' service
5
• Some GP staff may lack confidence in working with people with SMI 4
• It maintains a split between physical health (at GP) and mental health (in psychiatry), preventing the person from being 
seen holistically
1
• Lack of specialist knowledge of possible metabolic effects of antipsychotics amongst GPs 1
• If screening revealed a possible adverse effect of antipsychotics, such as diabetes, GP may lack the confidence to alter 
the antipsychotic
1
• It can be difficult to get an appointment with the GP 1
* Note: Tick-boxes indicate which group(s) of participants expressed the view: CMHT = staff from community mental health team; GP = staff from 
general practice; SU = service users. Numbers (N) indicate the prevalence of each view within the total sample.
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Table 3: Secondary care screening model: Advantages and disadvantages
View expressed by *
Perceived advantages of delivering screening in secondary care CMHT GP SU N
• CMHT staff have a better rapport and understanding of people with SMI 12
• CMHT has better access to and knowledge of people with SMI 8
• The CMHT setting and workers are less threatening for patients than the GP environment and easier to trust – this might reduce 
the non-attendance rates
6
• CMHT staff can access patients in a greater variety of settings, thus enhancing the uptake of screening 6
• It promotes a more holistic model of care – 'not just a prescription' 4
• It is better to unite clients' physical and mental health care in one place 3
• CMHT staff are more experienced than GPs in working assertively with people with SMI 3
• If the CHD risk factors are linked to having SMI, then the CMHT should take responsibility for screening 3
• Psychiatrists prescribe the antipsychotics which require risk factor screening 2
• CMHT workers have more time and can offer longer appointments 2
• It would allow CMHT staff to develop new skills 1
• There are shorter waiting times at CMHT compared to the GP 1
Perceived disadvantages
• The CMHT workload is already high – they lack the time for extra responsibilities 19
• Lack of skills and knowledge required for screening amongst care coordinators, especially those without nursing or medical 
training
12
• Lack of appropriate facilities – e.g. equipment, clinical rooms, access to blood results in community settings 9
• Unwillingness of CMHT staff to take on extra roles 8
• Lack of medical expertise in the CMHT regarding appropriate interventions if screening results are positive – care will either be 
inferior or simply result in re-referral to primary care.
5
• It blurs the role of the CMHT 5
• Some service users mistrust psychiatric services and don't want their involvement 4
• CMHTs only see the most severely mentally ill people, so some patients will be overlooked 3
• It would be stigmatising (not normalising) to have separate services for people with SMI 3
• Patients like to keep their mental health and physical health separate 3
• Mental health meetings such as Care Programme Approach meetings are inappropriate settings for screening 2
• It would cause stress for CMHT staff who might feel to blame if CHD morbidity was undetected 2
• Lack of continuity with CMHT staff – they tend to come and go more often than GP staff 2
• CMHT bases are less accessible than GPs geographically 1
* Note: Tick-boxes indicate which group(s) of participants expressed the view: CMHT = staff from community mental health team; GP = staff from general 
practice; SU = service users. Numbers (N) indicate the prevalence of each view within the total sample.
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who would know better than we would how to manage
these things and then would be monitoring them in the
longer-term. I think whoever is diagnosing them should
really be managing the conditions as well (Consultant
Psychiatrist 07).
Preference for a service for the primary prevention of CHD
in secondary care services was mentioned more frequently
by people with SMI, often because they felt more comfort-
able engaging with mental health staff.
Since it's geared towards mentally ill people, I think that
it should be done, if possible, within the mental health
service. I say that because, to me, I feel happier coming
here to talk about my problem ... my mental health prob-
lems ... with a specialist, rather than going to a GP, who's
fine but firstly they're not a specialist and secondly they
haven't really got much time (Service User 14).
When staff was asked to consider the benefits and disad-
vantages of both models in turn, a more complex picture
emerged. A variety of problems with the primary care
model were forthcoming (see Table 2). Poor uptake of
screening, lack of engagement of SMI patients with GPs,
poor communication of results from GPs to the CMHT
and lack of knowledge among GPs regarding the relation-
ship between antipsychotic medication and CHD risk
were common concerns.
This complexity was increasingly apparent when partici-
pants were asked to consider the pros and cons of a CMHT
based model of screening (see Table 3). Many people –
who had initially stated that primary care was the best set-
ting for primary prevention of CHD – began to identify
disadvantages to the primary care model and advantages
to the secondary care model which had not been immedi-
ately obvious. The benefits of the CMHT providing such a
service included having access to users who rarely visit
their GP and leaving the responsibility of early prevention
of CHD in the hands of those who managed their antipsy-
chotic medication.
Psychiatrists don't really often go below the neck ... in
terms of the things they look out for and, if they're going
to be handing out medicines, such as Risperidone or
Olanzapine or Quetiapine, which of course make people
fatter ... makes them diabetic ... then I think that's a
responsibility they have to take – of being able to screen
individuals for coronary heart disease and do something
about it (General Practitioner 10).
The main disadvantages were being overworked and pos-
sibly unfamiliar with blood results and appropriate inter-
ventions such as anti-hypertensives, lipid lowering
medication or diagnosis of diabetes and its management.
I think the risk would be that you're just filling in boxes
and maybe they'd come to the clinic, someone would
check their blood pressure, take the blood test, do the
height and weight ... and you'd tick the boxes and say,
"Right, we've done it" but then nothing really would be
done about it. And I think it would be the next step about
who would take the responsibility of saying, "Well, you've
got high blood pressure" or "Your cholesterol is too high.
We need to do something about it" ... and who then
would go on to do that. What would happen? (Psychia-
trist 23).
Shared care services or a service led by additional nursing 
staff
Having discussed the pros and cons of primary and sec-
ondary care screening, participants were asked to consider
the best way forward. Several staff spontaneously sug-
gested the need for improved collaboration between pri-
mary and secondary care services to ensure that screening
was provided coherently and comprehensively.
I suppose we've been thinking a bit 'either-or' but, in a
way, it's going to have to be 'both-and' because there's ...
you know, two-thirds of mental health we don't see [in
mental health services] anyway ... there are going to be
some patients who don't make it to us and there are going
to be some patients that we see who don't really make it
to the GP. So, if you want to cover the entire spectrum, I
think you need to do both (Psychiatrist 24).
However, there were still drawbacks to such models
including issues about confusion of roles, who was actu-
ally taking responsibility for provision of the screening
and for acting on any abnormal findings. Poor communi-
cation, especially from primary to secondary care, was
again felt to be a major flaw in joint (or collaborative)
working. Many participants agreed that one person
should take overall responsibility to ensure adequate
screening for risk factors of CHD – be it primary or sec-
ondary care – depending on patient, professional and
local service characteristics. When a specialist nurse-led
service was suggested to participants who had not raised it
spontaneously, they usually endorsed it. The perceived
benefits were its flexibility, greater accessibility for
patients, clarity of roles and ensuring good liaison
between primary and secondary care, irrespective of indi-
vidual patient or staff preferences for delivery of screening
(see Table 4).
I think it's always good to have somebody whose kind of
responsibility it is to make sure that things happen... I
mean, if there was funding. That person wouldn't neces-Page 8 of 12
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responsibility for making sure that it, you know, hap-
pened and coming round to the practices and saying,
"What are you doing?" and checking our records, or what-
ever, to find out (General Practitioner 01).
I think that [the specialist nurse model] would be best of
all, because of its flexibility and because of the recognition
that you really need to try and catch people in different
settings. In fact, there probably isn't a one-size-fits-all sce-
nario to offer this service really (Consultant Psychiatrist
25).
However, despite their enthusiasm, respondents were not
optimistic about the likelihood of health service funding
being available for this option.
Discussion
The views expressed by our participants suggest that the
provision of comprehensive screening for CHD risk fac-
tors in people with SMI is seen as a health service priority
by many patients, CMHT staff – including psychiatrists –
and general practice doctors and nurses. The provision of
such services, however, is likely to require complex mod-
els of care that cross primary and secondary care services
and allow for flexibility in staff and patient motivation,
and preferences for services, with an emphasis on commu-
nication between different elements of the service.
Prioritisation of physical health in SMI is partly explained
by observation of CHD risk factors and mortality in peo-
ple with SMI and growing concern regarding the adverse
effects of antipsychotic medications. The spontaneous
reaction of CMHT and GP staff in our sample was often
that CHD screening should remain the remit of primary
care services where it has traditionally been located. Serv-
ice users recruited from CMHTs were more divided in
their views and many said they would prefer to receive pri-
mary prevention of CHD as a service in their CMHT.
Despite this enthusiasm from patients, professionals felt
that the provision of CHD screening and relevant inter-
ventions would require more assertive effort in this
patient group.
Our participants' opinions indicate that provision of a
comprehensive CHD screening service is likely to require
a complex approach that crosses the primary-secondary
care interface. Many felt that models located solely in pri-
mary or secondary care would be unlikely to benefit all
patients. Individual patient factors (such as preference for
primary or secondary care settings and teams), individual
staff factors (knowledge, workload, motivation and inter-
est in mental illness or CHD screening) and communica-
tion factors could produce inconsistent levels of CHD-
related care in either primary or secondary care settings.
Many of our participants therefore concluded that a serv-
ice led by at least one person liaising between primary and
secondary care was the best solution.
The possibility of liaison across the primary secondary
interface is not a part of the growing body of recommen-
dations regarding the provision of physical health care
and screening for CHD risk factors such as diabetes, smok-
ing and dyslipidaemia in people with SMI. International
guidelines on the monitoring of CHD risk in schizophre-
nia suggest that screening for lipids and diabetes should
normally take place in primary care, unless the patient is
not in contact with such services [7,8]. In the UK, the new
GP contract places responsibility for an annual physical
health check upon primary care, and remunerates practi-
tioners if targets are met. However, the required content of
such check-ups does not automatically include diabetic
status or lipids. Furthermore there is no requirement to
communicate such CHD risk results back to secondary
care. The service users and professionals we interviewed
felt that this primary care model generated many prob-
lems. SMI lists tended to be stigmatising, essential clinical
information was unlikely to be available to the psychia-
trist managing the antipsychotic medications, and many
participants did not attend for routine appointments in
primary care. Some service users also cited difficulty
accessing primary care appointments.
Other international commentaries have suggested that
screening should become the remit of secondary care.
Since psychiatrists and CMHT staff are in more frequent
contact with people with SMI and since they prescribe
antipsychotic medication, it is stated that they should be
more familiar with CHD risk factors [6,7,12]. This view
was supported by many of our participants but it was also
evident that placing such responsibility on all CMHT staff
is not universally acceptable and would generate many
difficulties. Staff would require training in interpretation
of CHD risk factors and their management. Whilst some
CMHT staff welcomed the opportunity to expand their
skills, others felt that such training would detract from
their mental health and social work skills, and might even
lead to people with SMI receiving an inefficient or inade-
quate service for the primary prevention of CHD, com-
pared to the services provided to the general population in
primary care.
CHD screening requires specialist knowledge on interpre-
tation of blood results and a knowledge of which inter-
ventions are required within what timeframe, for different
magnitudes of CHD risk factors. This necessitates repeated
measurement of risk factors to assess the effect of the
interventions. These more complex components of pri-
mary prevention of CHD cannot be expected of CMHTs,
and therefore raise important questions about the level ofPage 9 of 12
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View expressed by *
Perceived advantages CMHT GP SU N
• There would be greater 
accessibility to screening 
for patients
5
• It would introduce more 
flexibility into a system 
which otherwise only suits 
certain patient profiles
4
• The nurse would provide 
specialist cross-disciplinary 
knowledge in a complex 
area that few CMHT staff 
or GPs feel wholly 
confident in.
4
• This model has worked 
successfully in other areas 
e.g. offering HIV testing in a 
drug dependency unit; a 
hepatitis nurse attached to 
a community drug team
3
• A nurse could bridge the 
existing gaps between 
primary and secondary 
care
3
• It would prevent the 
burden falling on already 
overworked CMHT 
workers and allow them to 
concentrate on their 
"traditional [mental health] 
work".
3
• Mobile services are also 
successful e.g. breast 
screening, needle 
exchanges
3
• It would facilitate 
communication, allow 
monitoring of the service 
and improve liaison 
between different parts of 
the service.
3
• It would allow a trusting 
ongoing clinical relationship 
to be established with the 
specialist nurse who knows 
about physical health issues
2
• The nurse could take on 
additional roles e.g. running 
interventions, groups, 
prescribing
1
• Someone needs to take 
specific responsibility to 
ensure that screening does 
happen
1
• One specialist nurse 
could be employed across 
whole Primary Care Trusts
1
Perceived 
disadvantages
• There might be too much 
or (in the view of a 
different participant) too 
little work for the specialist 
nurse to provide
7
? ? ?
? ?
? ?
? ?
? ?
? ?
? ?
? ? ?
?
?
?
?
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remains that while GPs are monitoring raised CHD risk,
psychiatrists who possess knowledge regarding antipsy-
chotics need to be aware of lipid, diabetic or other CHD
complications which would influence the risk/benefit
equation sufficiently to change their choice of prescrip-
tion. High rates of CHD risk factors in this group of
patients necessitate assertive efforts to offer screening and
relevant interventions for people with SMI. Our research
demonstrates that the interface between primary care and
CMHTs potentially creates multiple pitfalls to providing
such services. If primary prevention services are to be suc-
cessful, they will need to overcome a range of obstacles.
Some of the barriers our participants identified are spe-
cific to people with SMI, such as experience or perception
of stigma regarding their mental health. Others are non-
specific, such as dislike of blood tests. Comprehensive
services must overcome diverse training needs at primary
and secondary care levels, as well as the reluctance and
incompetence of some staff to provide appropriate screen-
ing or to engage people with SMI. Liaison is required
between those providing potentially diabetogenic or
weight promoting antipsychotics, those monitoring men-
tal state, and those providing interventions for CHD risk
factors.
The findings of our qualitative study offer a unique insight
into the views of service users and NHS staff in relation to
the primary prevention of CHD in SMI. To our knowl-
edge, there has been no previous research to address the
question of how best to organise clinical services to pre-
vent heart disease in this 'at risk' patient group. Obtaining
the views of stakeholder groups is an important first step
in developing services that are likely to be acceptable to
both service users and providers.
Study limitations
Our in-depth interviews have explored the views of three
important stakeholder groups – i.e. patients with SMI,
staff from general practice and staff from CMHTs. How-
ever, there are limitations to the conclusions that can be
draw from data collected from a relatively small sample
recruited from two inner London boroughs. Care there-
fore should be taken when generalising our findings to
other services or settings. The possibility of response bias
also exists, in that service users and staff with a particular
interest in the topic may have been more likely to agree to
participate in an interview. Thus the opinions of those
who do not view the prevention of CHD in SMI as a high
priority may be under-represented. Nonetheless, the use
of qualitative methods has enabled us to obtain a better
understanding of the reasons why service users and health
professionals hold certain preferences for care delivery.
Conclusion
Our results suggest that a complex solution is required to
this complex problem. Research is required to evaluate the
clinical and cost effectiveness of interventions to improve
rates of CHD risk factor screening in people with SMI.
Such interventions need to straddle primary and second-
ary care services, be flexible and accessible, and provide
effective communication and liaison between relevant
health professionals. One or more individuals need to
take responsibility for this role and we are currently devel-
• It would be an expensive 
option and thus is unlikely 
to be prioritised or 
commissioned – non-
attendance rates may be 
too high to justify the cost
6
• It adds another person 
into the health service 
equation and complicates it
2
• It might encourage 
further dependence on the 
service by people with SMI, 
rather than them accessing 
their GP like everybody 
else
1
• It may make patients link 
physical side effects to 
their antipsychotic 
medication, encouraging 
cessation of treatment
1
• It may create suspicion 
when SMI patients feel 
"singled out" for a special 
service
1
* Note: Tick-boxes indicate which group(s) of participants expressed the view: CMHT = staff from community mental health team; GP = staff from 
general practice; SU = service users. Numbers (N) indicate the prevalence of each view within the total sample.
Table 4: Views regarding a specialist nurse model for providing CHD screening in SMI (Continued)
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and provide it him/herself if neither option succeeds.
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